Literature DB >> 7483143

Doxorubicin treatment of rabbit renal VX-2 carcinoma: nephrotoxicity, serum parameters and weight.

G Gadeholt-Göthlin1, H Vik, J H Göthlin.   

Abstract

Serum electrolytes, creatinine, urea, protein, albumin, bilirubin and glucose were examined every 4 days until time of death in rabbits with VX-2 carcinoma implanted in one kidney. The rabbits were treated with doxorubicin, nephrectomy or combinations thereof and observed for up to 1 year. Rabbits treated with doxorubicin only showed a slight creatinine rise initially, but over time creatinine reached almost the same concentration as that in nephrectomized rabbits receiving equivalent doses of doxorubicin. Creatinine concentrations increased significantly above the normal range following nephrectomy combined with doxorubicin. Doxorubicin nephrotoxicity in rabbits occurs at lower doses than previously reported. In all rabbits the parameters except creatinine remained stable within the established normal ranges, except for the last 4 days before time of death in the animals with metastatic disease. Weight loss was the best parameter for making a prognosis for an individual rabbit, since peak weight was noted 16-20 days before death. In experimental work with VX-2 carcinoma, weight is thus the most important indicator of the time at which rabbits not responding to treatment can be put to death to avoid unnecessary suffering before the end of the experiment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483143     DOI: 10.1007/bf00389569

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  22 in total

1.  HYPERPARATHYROID-LIKE STATE IN RABBITS WITH THE VX-2 CARCINOMA: FURTHER STUDIES.

Authors:  J R WILSON; H MERRICK; S D VOGEL; E R WOODWARD
Journal:  Am Surg       Date:  1965-02       Impact factor: 0.688

2.  Hypercalcemia simulating hyperparathyroidism induced by XV-2 carcinoma of rabbit.

Authors:  J R WILSON; H MERRICK; E R WOODWARD
Journal:  Ann Surg       Date:  1961-10       Impact factor: 12.969

3.  Normal biochemical and hematological values in New Zealand white rabbits.

Authors:  C D Hewitt; D J Innes; J Savory; M R Wills
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

4.  Adriamycin and daunorubicin disposition in the rabbit.

Authors:  N R Bachur; R C Hildebrand; R S Jaenke
Journal:  J Pharmacol Exp Ther       Date:  1974-11       Impact factor: 4.030

5.  Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone.

Authors:  H J Wolfe; W R Bitman; E F Voelkel; H J Griffiths; A H Tashjian
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

6.  Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.

Authors:  A Hough; H Seyberth; J Oates; W Hartmann
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

7.  Clinical and pathologic features of chronic adriamycin toxicosis in rabbits.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Vet Res       Date:  1980-09       Impact factor: 1.156

8.  Dose-response relationships of chronic adriamycin toxicity in rabbits.

Authors:  H J Long; S S Diamond; C P Raflo; R A Burningham
Journal:  Eur J Cancer Clin Oncol       Date:  1984-01

9.  VX2 carcinoma, pulmonary metastases, and neutrophilic leukocytosis. Possible animal model of tumor-associated granulocytosis.

Authors:  A J Hough; W C Hubbard; J A Oates
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

10.  Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.

Authors:  R S Jaenke; D Deprez-DeCampeneere; A Trouet
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.